Cheryl Cheng
Founder and CEO @ Vive Collective
Menlo Park, United States
Cheryl Cheng is a Series A investor at Vive Collective in Menlo Park focused on Health Care and SaaS. Cheryl Cheng joined BRV in 2008. She focuses on early stage consumer and mobile big data opportunities. Cheryl also runs BRV’s alumni entrepreneur and Fortune 500 programs to bring experience and resources to the current portfolio. Prior to BlueRun, Cheryl worked at Clorox and The Sharper Image launching new products and driving retail marketingwith partners across Target, Walmart and grocery.Cheryl has a B.A. from Stanford University and an MBA from Kellogg School of Management where she was a Forte Scholar. She is a mentor at Stanford’s Bio-Design for Mobile Health course, a collaboration between Stanford’s School of Medicine and School of Engineering.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Cheryl Cheng invests in
Stages Cheryl Cheng invests in
Countries Cheryl Cheng invests in
Round sizes
Round size
- Seed
- $2M–$5M
- Series A
- $4.7M–$30M
Investment Focus
Industry
- Health Care 3 (25%)
- SaaS 2 (17%)
- Email 2 (17%)
- Content 2 (17%)
- Computer 2 (17%)
Stage
- Series A 8 (67%)
- Seed 3 (25%)
- Series B 1 (8%)
Country
- United States 8 (67%)
- Canada 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Didero
|
The AI agent for procurement | $30M / Series A / Feb 12, 2026 | |
SamaCare
|
SamaCare works with manufacturers' medically administered products to optimize the prior authorization process while remaining in compliance. The company offers a cloud-based workflow automation platform designed to streamline specialty drug prior authorization, enrollment, and benefit verification for medical practices. Additionally, SamaCareprovides premium services and data analytics to pharmaceutical brands, enhancing access to therapies. | $17M / Series B / May 21, 2024 | |
|
SamaCare
|
SamaCare works with manufacturers' medically administered products to optimize the prior authorization process while remaining in compliance. The company offers a cloud-based workflow automation platform designed to streamline specialty drug prior authorization, enrollment, and benefit verification for medical practices. Additionally, SamaCareprovides premium services and data analytics to pharmaceutical brands, enhancing access to therapies. | $12M / Series A / Feb 01, 2022 | |
Kiddo
|
Kiddo is a personalized smart at-home health monitoring platform for children. The Kiddo band is a smart pediatric band for children ages 3+ designed to track key vital signs – perspiration, activity, heart rate, and skin temperature. Along with the Kiddo companion app, Kiddo provides actionable health insights to parents combined with alerts andrecommendations. Kiddo also enables care integrations such as Telehealth and Doctor Appointments (in select markets only) thus enabling providers to manage admission rates and deliver cost-optimal proactive care. | $16M / Series A / Jan 04, 2022 | |
Gennev
|
Gennev is a digital health company for women such as midlife and menopause. Gennev increases accessibility to information, health providers, and the community for women seeking relief for hormone-driven symptoms like hot flashes, insomnia, anxiety, and loss of libido. The company was founded in 2015 and headquartered in Seattle, Washington. | $4M / Seed / Aug 06, 2019 | |
Sendwithus
|
Dyspatch, the product by Sendwithus, is a cloud-based, communications management platform that allows Enterprise organizations to centralize email security, compliance, and reputation management while streamlining collaborative creation, revision, and approval workflows. The GDPR-compliant solution empowers teams to deliver powerful, globalcommunications that engage customers, drive growth, and increase revenue. Sendwithus has been helping leading brands craft exceptional communications experiences since 2013. | $5M / Series A / Nov 21, 2017 | |
Dyspatch
|
Dyspatch is an email production platform that helps Enterprise organizations create and change transactional and triggered emails faster, by centralizing template creation, approval, and publishing processes. The powerful API, visual editor, and built-in device testing allow for cutting-edge email strategy and execution, while helping establishconsistency in both branding and legal compliance across multiple teams, departments, and business units. | $5M / Series A / Nov 21, 2017 | |
|
Dyspatch
|
Dyspatch is an email production platform that helps Enterprise organizations create and change transactional and triggered emails faster, by centralizing template creation, approval, and publishing processes. The powerful API, visual editor, and built-in device testing allow for cutting-edge email strategy and execution, while helping establishconsistency in both branding and legal compliance across multiple teams, departments, and business units. | $5M / Seed / Nov 21, 2017 | |
Nom
|
Nom lets anyone host professional cooking, creative and DIY shows, and tap into its network of makers, creators, and chefs. | $4.7M / Series A / Mar 09, 2016 | |
ZeeMee
|
ZeeMee is a free platform for students to bring their college applications to life. With over 1 billion photos shared on Snapchat daily, Generation Z resonates deeply with ZeeMee, as it allows them to tell their whole story and express themselves completely in the application process. Core to ZeeMee’s mission is the desire to enable greater accessand equity for students around the globe in the college application process and facilitate a medium via which students and colleges can connect professionally. In order to achieve our mission, we offer ZeeMee as a free platform to all students around the world. ZeeMee allows students, regardless of their socioeconomic status, to express themselves in ways traditional applications often fail. As a result, we have been well received in school districts across the country and by universities that are committed to holistic review and access for all. We are excited to partner with schools across the U.S. that deeply value each student’s unique story and desire to bolster equity and access for all. While helping students showcase their passions, ZeeMee works closely with colleges for free to help them connect with Gen Z in fresh, innovative ways, improving recruitment, selection and retention. | $5.8M / Series A / Oct 01, 2015 | |
| See all 12 investments → | |||
Co-Investors
About Vive Collective
Vive Collective is involved in improving quality and access to care by developing, funding, and growing digital health companies.
Vive Collective Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Cheryl Cheng
Founder and CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cheryl Cheng invest in?
Cheryl Cheng invests primarily in Health Care, SaaS and Email startups, most often at Series A and Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cheryl Cheng's check size?
Cheryl Cheng typically joins rounds of $2M–$5M at Seed and $4.7M–$30M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cheryl Cheng participates in.
When did Cheryl Cheng last invest?
The most recent investment recorded for Cheryl Cheng closed in Feb 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
